BRIEF TOC
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Acromegaly Market, by Type
6.1 Introduction
6.2 Ectopic Acromegaly
6.2.1 Market Estimates & Forecast, 2020-2027
6.3 Acromegaly due to Growth Hormone
6.3.1 Market Estimates & Forecast, 2020-2027
6.4 Others
6.4.1 Market Estimates & Forecast, 2020-2027
Chapter 7. Global Acromegaly Market, by Diagnosis
7.1 Introduction
7.2 Medical Imaging
Market Estimates & Forecast, 2020-2027
7.2.1 Radiography
7.2.2 Magnetic Resonance Imaging (MRI)
7.2.3 Nuclear Medicine
7.2.4 Ultrasound
7.2.5 Others
7.3 Medical Laboratory Investigations
Market Estimates & Forecast, 2020-2027
7.4 Others
Market Estimates & Forecast, 2020-2027
Chapter 8. Global Acromegaly Market, by Treatment
8.1 Introduction
8.2 Medications
Market Estimates & Forecast, 2020-2027
8.2.1 Somatostatin Analogues
8.2.2 Dopamine Agonists
8.2.3 Growth Hormone Receptor Antagonists
8.2.4 Others
8.3 Surgery
Market Estimates & Forecast, 2020-2027
8.3.1 Endonasal Transphenoidal Surgery
8.3.2 Transphenoidal Surgery
8.4 Radiation Diagnosis
Market Estimates & Forecast, 2020-2027
8.5 Others
Market Estimates & Forecast, 2020-2027
Chapter 9. Global Acromegaly Market, by End User
9.1 Introduction
9.2 Hospitals
9.2.1 Market Estimates & Forecast, 2020-2027
9.3 Clinics
9.2.2 Market Estimates & Forecast, 2020-2027
9.4 Others
Chapter 10. Global Acromegaly Market, by Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 US
10.2.1.1 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12. Company Profiles
12.1 Novartis AG
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 Aegis Therapeutics LLC
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Chiasma Inc
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Crinetics Pharmaceuticals Inc
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Daewoong Pharmaceutical Co Ltd
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 Silence Therapeutics Plc
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 Strongbridge Biopharma plc
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Others
Chapter 13. MRFR Conclusion
13.1 Key Findings
13.1.1 From CEOโs View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Acromegaly industry
Chapter 14. Appendix
DATA TABLES
Table 1 Acromegaly Industry Synopsis, 2020-2027
Table 2 Global Acromegaly Market Estimates and Forecast, 2020-2027, (USD Million)
Table 3 Global Acromegaly Market by Region, 2020-2027, (USD Million)
Table 4 Global Acromegaly Market by Types, 2020-2027, (USD Million)
Table 5 Global Acromegaly Market by Diagnosis, 2020-2027, (USD Million)
Table 6 Global Acromegaly Market by Treatment, 2020-2027, (USD Million)
Table 7 Global Acromegaly Market by End Users, 2020-2027, (USD Million)
Table 8 North America Acromegaly Market by Types, 2020-2027, (USD Million)
Table 9 North America Acromegaly Market by Diagnosis, 2020-2027, (USD Million)
Table 10 North America Acromegaly Market by Treatment, 2020-2027, (USD Million)
Table 11 North America Acromegaly Market by End Users, 2020-2027, (USD Million)
Table 12 US Market by Types, 2020-2027, (USD Million)
Table 13 US Acromegaly Market by Diagnosis, 2020-2027, (USD Million)
Table 14 US Acromegaly Market by Treatment, 2020-2027, (USD Million)
Table 15 US Acromegaly Market by End Users, 2020-2027, (USD Million)
Table 16 Canada Market by Types, 2020-2027, (USD Million)
Table 17 Canada Acromegaly Market by Diagnosis, 2020-2027, (USD Million)
Table 18 Canada Acromegaly Market by Treatment, 2020-2027, (USD Million)
Table 19 Canada Acromegaly Market by End Users, 2020-2027, (USD Million)
Table 20 South America Market by Types, 2020-2027, (USD Million)
Table 21 South America Acromegaly Market by Diagnosis, 2020-2027, (USD Million)
Table 22 South America Acromegaly Market by Treatment, 2020-2027, (USD Million)
Table 23 South America Acromegaly Market by End Users, 2020-2027, (USD Million)
Table 24 Europe Market by Types, 2020-2027, (USD Million)
Table 25 Europe Acromegaly Market by Diagnosis, 2020-2027, (USD Million)
Table 26 Europe Acromegaly Market by Treatment, 2020-2027, (USD Million)
Table 27 Europe Acromegaly Market by End Users, 2020-2027, (USD Million)
Table 28 Western Europe Market by Types, 2020-2027, (USD Million)
Table 29 Western Europe Acromegaly Market by Diagnosis, 2020-2027, (USD Million)
Table 30 Western Europe Acromegaly Market by Treatment, 2020-2027, (USD Million)
Table 31 Western Europe Acromegaly Market by End Users, 2020-2027, (USD Million)
Table 32 Eastern Europe Market by Types, 2020-2027, (USD Million)
Table 33 Eastern Europe Acromegaly Market by Diagnosis, 2020-2027, (USD Million)
Table 34 Eastern Europe Acromegaly Market by Treatment, 2020-2027, (USD Million)
Table 35 Eastern Europe Acromegaly Market by End Users, 2020-2027, (USD Million)
Table 36 Asia Pacific Market by Types, 2020-2027, (USD Million)
Table 37 Asia Pacific Acromegaly Market by Diagnosis, 2020-2027, (USD Million)
Table 38 Asia Pacific Acromegaly Market by Treatment, 2020-2027, (USD Million)
Table 39 Asia Pacific Acromegaly Market by End Users, 2020-2027, (USD Million)
Table 40 Middle East & Africa Market by Types, 2020-2027, (USD Million)
Table 41 Middle East & Africa Acromegaly Market by Diagnosis, 2020-2027, (USD Million)
Table 42 Middle East & Africa Acromegaly Market by Treatment, 2020-2027, (USD Million)
Table 43 Middle East & Africa Acromegaly Market by End Users, 2020-2027, (USD Million)
FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Acromegaly Market
Figure 3 Segmentation Market Dynamics for Global Acromegaly Market
Figure 4 Global Acromegaly market Share, by type 2020
Figure 5 Global Acromegaly market Share, by Diagnosis 2020
Figure 6 Global Acromegaly market Share, by Treatment 2020
Figure 7 Global Acromegaly Market Share, by End Users, 2020
Figure 8 Global Acromegaly Market Share, by Region, 2020
Figure 9 North America Acromegaly Market Share, by Country, 2020
Figure 10 Europe Acromegaly Market Share, by Country, 2020
Figure 11 Asia Pacific Acromegaly Market Share, by Country, 2020
Figure 12 Middle East & Africa Acromegaly Market Share, by Country, 2020
Figure 13 Global Acromegaly Market: Company Share Analysis, 2020 (%)
Figure 14 Novartis AG: Key Financials
Figure 15 Novartis AG: Segmental Revenue
Figure 16 Novartis AG: Geographical Revenue
Figure 17 Aegis Therapeutics LLC: Key Financials
Figure 18 Aegis Therapeutics LLC: Segmental Revenue
Figure 19 Aegis Therapeutics LLC: Geographical Revenue
Figure 20 Chiasma Inc.: Key Financials
Figure 21 Chiasma Inc.: Segmental Revenue
Figure 22 Chiasma Inc.: Geographical Revenue
Figure 23 Crinetics Pharmaceuticals Inc.: Key Financials
Figure 24 Crinetics Pharmaceuticals Inc.: Segmental Revenue
Figure 25 Crinetics Pharmaceuticals Inc.: Geographical Revenue
Figure 26 Daewoong Pharmaceutical Co Ltd.: Key Financials
Figure 27 Daewoong Pharmaceutical Co Ltd.: Segmental Revenue
Figure 28 Daewoong Pharmaceutical Co Ltd.: Geographical Revenue
Figure 29 Silence Therapeutics Plc: Key Financials
Figure 30 Silence Therapeutics Plc: Segmental Revenue
Figure 31 Silence Therapeutics Plc: Geographical Revenue
Figure 32 Strongbridge Biopharma plc.: Key Financials
Figure 33 Strongbridge Biopharma plc.: Segmental Revenue
Figure 34 Strongbridge Biopharma plc.: Geographical Revenue